American Oriental Bioengineering (AOBI) Stock Price & Analysis
AOBI Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.01
- Previous Close
- $0.01
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $949
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 0.0
- Beta
- 0.38
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
AOBI FAQ
What was American Oriental Bioengineering’s price range in the past 12 months?
What is American Oriental Bioengineering’s market cap?
When is American Oriental Bioengineering’s upcoming earnings report date?
Is American Oriental Bioengineering overvalued?
Does American Oriental Bioengineering pay dividends?
What is American Oriental Bioengineering’s EPS estimate?
How many shares outstanding does American Oriental Bioengineering have?
Which hedge fund is a major shareholder of American Oriental Bioengineering?
What is the TipRanks Smart Score and how is it calculated?
Company Description
American Oriental Bioengineering
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shujun Liu
- Employees
- 3,719
- Website
- www.bioaobo.com
- Address
- 1 First Liangshuihe Avenue, Beijing, BE, 100176, CN
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 4 |
| Technical Analysis | 2 | 1 | 0 |
| Moving Averages | 2 | 2 | 4 |
